Literature DB >> 21710205

TGF-β1 stimulates mouse macrophages to express APRIL through Smad and p38MAPK/CREB pathways.

Young-Saeng Jang1, Jae-Hee Kim, Goo-Young Seo, Pyeung-Hyeun Kim.   

Abstract

A proliferation-inducing ligand (APRIL), a new TNF family member, supports B-cell survival and tumor cell proliferation. APRIL is secreted as a soluble protein by macrophages, dendritic cells and activated T cells. However, factors involved in regulation of APRIL expression are as yet unknown. In this study, we investigated the effect of TGF-β1 on APRIL expression in P388D1, a mouse macrophage cell line. TGF-β1 induced APRIL mRNA expression in a time- and dose-dependent manner. One nanogram per milliliter of TGF-β1 was optimal and APRIL transcripts appeared as early as 3 h after stimulation. Based on our studies, which included overexpression of Smad3, DN-Smad3, and sh-Smad3, we found that Smad3 mediates APRIL transcription at least partially. Further, experiments using inhibitors revealed that p38MAPK and CREB are also involved in TGF-β1-induced APRIL expression. These results suggest that TGF-β1, through Smad3 and p38MAPK/CREB signaling pathways, stimulates APRIL expression in macrophages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710205      PMCID: PMC3887634          DOI: 10.1007/s10059-011-1040-4

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  31 in total

1.  Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction.

Authors:  K Yamaguchi; K Shirakabe; H Shibuya; K Irie; I Oishi; N Ueno; T Taniguchi; E Nishida; K Matsumoto
Journal:  Science       Date:  1995-12-22       Impact factor: 47.728

2.  TGF-beta signaling in murine embryonic palate cells involves phosphorylation of the CREB transcription factor.

Authors:  M B Potchinsky; W M Weston; M R Lloyd; R M Greene
Journal:  Exp Cell Res       Date:  1997-02-25       Impact factor: 3.905

Review 3.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

4.  A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.

Authors:  T Moriguchi; N Kuroyanagi; K Yamaguchi; Y Gotoh; K Irie; T Kano; K Shirakabe; Y Muro; H Shibuya; K Matsumoto; E Nishida; M Hagiwara
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

Review 5.  What turns CREB on?

Authors:  Mona Johannessen; Marit Pedersen Delghandi; Ugo Moens
Journal:  Cell Signal       Date:  2004-11       Impact factor: 4.315

6.  A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals.

Authors:  D Goto; K Yagi; H Inoue; I Iwamoto; M Kawabata; K Miyazono; M Kato
Journal:  FEBS Lett       Date:  1998-07-03       Impact factor: 4.124

7.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.

Authors:  X H Feng; Y Zhang; R Y Wu; R Derynck
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

8.  Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes.

Authors:  R L Coffman; D A Lebman; B Shrader
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes.

Authors:  B Dubois; B Vanbervliet; J Fayette; C Massacrier; C Van Kooten; F Brière; J Banchereau; C Caux
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells.

Authors:  T M McIntyre; D R Klinman; P Rothman; M Lugo; J R Dasch; J J Mond; C M Snapper
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  5 in total

1.  Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.

Authors:  Payam Nahid; Erin Bliven-Sizemore; Leah G Jarlsberg; Mary A De Groote; John L Johnson; Grace Muzanyi; Melissa Engle; Marc Weiner; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  Tuberculosis (Edinb)       Date:  2014-02-07       Impact factor: 3.131

2.  miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation.

Authors:  Samir Kelada; Praveen Sethupathy; Isobel S Okoye; Eleni Kistasis; Stephanie Czieso; Sandra D White; David Chou; Craig Martens; Stacy M Ricklefs; Kimmo Virtaneva; Dan E Sturdevant; Stephen F Porcella; Yasmine Belkaid; Thomas A Wynn; Mark S Wilson
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

3.  Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks.

Authors:  Sarah J Lessard; Donato A Rivas; Ana B Alves-Wagner; Michael F Hirshman; Iain J Gallagher; Dumitru Constantin-Teodosiu; Ryan Atkins; Paul L Greenhaff; Nathan R Qi; Thomas Gustafsson; Roger A Fielding; James A Timmons; Steven L Britton; Lauren G Koch; Laurie J Goodyear
Journal:  Diabetes       Date:  2013-04-22       Impact factor: 9.461

4.  Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?

Authors:  Francesca Polverino; Maria Laucho-Contreras; Joselyn Rojas Quintero; Miguel Divo; Victor Pinto-Plata; Lynette Sholl; Juan P de-Torres; Bartolome R Celli; Caroline A Owen
Journal:  Multidiscip Respir Med       Date:  2016-04-04

5.  A Proliferation-Inducing Ligand Regulation in Polymorphonuclear Neutrophils by Panax ginseng.

Authors:  Wioletta Ratajczak-Wrona; Natalia Wawrusiewicz-Kurylonek; Marzena Garley; Adam Jacek Kretowski; Ewa Jablonska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2020-10-13       Impact factor: 4.291

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.